PC3 Инь-тан - analogs
| Prices in pharmacies: Instructions PC3 Инь-тан | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Hexicon D ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 27% Bl 66 neutral
- 22% Bl 2 neutral
- 20% Bl 60 neutral
- 20% Bl 4 neutral
- 19% Bl 67 neutral
- 19% Bl 58 neutral
- 19% Du 24 neutral
- 19% Bl 19 neutral
- 18% Gb 21 neutral
- 17% Du 16 neutral
- 16% Gb 20 neutral
- 16% Gb 44 neutral
- 15% Gb 34 neutral
- 15% Bl 57 neutral
- 14% Bl 40 neutral
- 14% L.i. 20 neutral
- 14% Tb 16 neutral
- 14% Bl 63 neutral
- 14% Du 26 neutral
- 14% Du 28 neutral
- 14% Bl 7 neutral
- 13% Du 20 neutral
- 13% Gb 39 neutral
- 13% L.i. 19 neutral
- 13% Gb 30 neutral
- 13% Bl 18 neutral
- 13% Bl 59 neutral
- 13% L.i. 9 neutral
- 12% L.i. 2 neutral
- 12% Gb 43 neutral
- 12% Ren 24 neutral
- 12% Bl 45 neutral
- 11% L.i. 11 neutral
- 11% Lu 11 neutral
- 11% Si 3 neutral
- 11% Gb 3 neutral
- 11% Bl 65 neutral
- 11% Bl 9 neutral
- 11% Gb 12 neutral
- 11% Bl 12 neutral
- 11% Bl 56 neutral
- 10% Liv 3 neutral
- 10% Liv 2 neutral
- 10% Gb 41 neutral
- 10% Bl 20 neutral
- 10% St 44 neutral
- 10% L.i. 10 neutral
- 10% Gb 31 neutral
- 10% Gb 4 neutral
- 10% Ren 13 neutral
Learn more about the selection of analogues
- The drug has «PC3 Инь-тан» no complete analogues; 51 analog by action, the most similar - Bl 66 .
- Medical online service has selected the best substitutes for PC3 Инь-тан based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues PC3 Инь-тан to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.